Hikma Pharmaceuticals (OTCMKTS:HKMPY) Trading 21.1% Higher

Hikma Pharmaceuticals Plc (OTCMKTS:HKMPY) shares were up 21.1% during mid-day trading on Thursday . The stock traded as high as $51.36 and last traded at $51.36, approximately 200 shares traded hands during trading. A decline of 60% from the average daily volume of 494 shares. The stock had previously closed at $42.41.

The business has a 50 day moving average of $48.90 and a 200-day moving average of $45.69.

Hikma Pharmaceuticals Company Profile (OTCMKTS:HKMPY)

Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment manufactures, markets, and sells generic injectable products for therapeutic categories, including anti-infective, anaesthetic, central nervous system (CNS), oncology, and pain management, as well as controlled substances and cardiovascular products.

Read More: Limitations of analyzing profit margin

Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.